Millie
your market intelligence analyst
Search Results
515 results
Your search is now limited to «Latest News on Drugs for Immune System Diseases» expert search.
News-Medical.net 02/16/2020 14:31
There are several theories to explain the high prevalence of fatty liver among HIV-positive patients, explains Dr. Sebastiani: "It is possibly due to HIV-related inflammation, the antiretroviral drugs that they have to take lifelong, and to very frequent metabolic problems, such as diabetes and high lipids.
More from News-Medical.net:
FeedNavigator (EU) 02/14/2020 12:11
However, there are limited evidences demonstrating their Potential modulatory functions in the immune system.
More from FeedNavigator (EU):
Daijiworld.com (India) 02/14/2020 06:29
... top leadership of the Young Mizo Association (YMA), a most influential body in Mizoram, recently met the governor and sought his help to strengthen cooperation between the government and NGOs in order to fight against drugs abuse and HIV/AIDS on a war footing.
More from Daijiworld.com (India):
European Respiratory Journal 02/14/2020 06:10
Bedaquiline is a highly effective drug for tuberculosis (TB) and is an important part of current regimens for drug-resistant TB. Bedaquiline resistance is rarely tested in operational settings. In a prospective cohort of 292 patients with drug-resistant TB and HIV starting bedaquiline in KwaZulu-Natal, South Africa, we whole genome sequenced isolates from 92 baseline culture positive patients. Five patients were infected with strains harbouring mutations associated with bedaquiline resistance, and an additional five acquired resistance mutations during treatment. Among the baseline culture positive patients, those with baseline or acquired resistance mutations had substantially worse clinical outcomes compared to patients without. Given the.
Medindia.com 02/12/2020 08:07
Antimalarial drugs are actively used to treat lupus symptoms long-term," says study senior author Mary de Vera, a professor of pharmaceutical sciences at UBC and the Canada Research Chair in Medication Adherence, Utilization and Outcomes.
More from Medindia.com:
DoctorsLounge 02/11/2020 20:00
For patients initiating therapy for advanced HIV, the addition of maraviroc, an antiretroviral drug with immunologic effects, to standard combined antiretroviral therapy does not improve clinical outcomes, according to a study published online Feb. 11 in the Annals of Internal Medicine.
More from DoctorsLounge:
Immune Therapeutics is actively developing T-cell activation immunotherapies in combination with other drug candidates to achieve immunomodulation in patients with cancer, auto-immune disease and inflammatory diseases.
More from Middle East North Africa Financial Network (MENAFN):
Healio News 02/10/2020 17:20
In addition to its efficacy as an antiretroviral, previous research has indicated that the C-C chemokine receptor type 5 antagonist maraviroc (Selzentry, Pfizer) could have immunologic effects, according to the study authors.
More from Healio News:
This stigma that HIV is a 'gay disease' was shaped by the 1980s and 90s HIV and AIDS epidemic and persists today.
More from Mail on Sunday (United Kingdom):
AIDS Research & Therapy 02/09/2020 19:00
In this regard, the World Health Organization developed a global strategy for the prevention and assessment of HIV drug resistance to support an approach for monitoring and surveillance in public health [16, 17.
More from AIDS Research & Therapy:
Guardian (United Kingdom) 02/07/2020 11:56
Gilead, a company that makes HIV drugs, has announced it will trial its drug remdesivir in the coronavirus outbreak.
More from Guardian (United Kingdom):
Start Printed Page 7216 The Food and Drug Administration (FDA, the Agency, or we) is classifying the human immunodeficiency virus (HIV) drug resistance genotyping assay using next generation sequencing (NGS) technology into class II (special controls.
More from Federal Register - Public Inspection (OFR):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications